Clinical Trials in Pittsburgh

Showing 13361-13380 of 21,047 trials

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

NCT02556177

This is an open-label, non-randomized, prospective, multi-site, parallel group (segment), hypothesis-generating study designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical neuropsychological assessments and GE Research Pack II advanced MR imaging in mTBI patients. The results are primarily intended for scientific inquiry and engineering development purposes, and may be used in future regulatory submissions.

ConcussionTraumatic Brain Injury

GE Healthcare477 participantsStarted Nov 2015

San Diego, California, United States • San Francisco, California, United States • Miami, Florida, United States +4 more locations

COMPLETEDPhase 277 miles

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

NCT01890746

The purpose of this randomized, blinded, placebo-controlled study was to provide clinical safety and exploratory efficacy data on the use of Eltrombopag in adult subjects with Acute Myeloid Leukemia (AML) receiving standard induction chemotherapy with daunorubicin plus cytarabine. A minimum of 120 evaluable subjects newly diagnosed with AML was stratified by antecedent malignant hematologic disorder and age.

Acute Leukaemia

Novartis Pharmaceuticals148 participantsStarted Sep 2013

Farmington, Connecticut, United States • Miami, Florida, United States • Orlando, Florida, United States +39 more locations

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

Find Trials by Condition in Pittsburgh

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

A Study of LY2541546 in Women With Low Bone Mineral Density

A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis

Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

A Study LY2228820 for Recurrent Ovarian Cancer

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

A Study of Advanced or Metastatic Non-small Cell Lung Cancer

The Patient-Reported Outcomes Project of HCV-TARGET

Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age

A Study in Advanced Cancer

Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer